I am currently accepting applications for graduate students starting Fall 2025 or later. Please email Dr. Jennifer Estall directly if you are interested specifically in my lab. If you are interested in the IRCM for graduate studies, but haven’t yet chosen a lab, you can apply through this website.
I am accepting post-doc applications for a project involving Therapeutic Development and In Vivo Beta Cell Targeting, with a start date of Summer 2025. See below for further information.
If you are an undergraduate student seeking a full-time summer internship and have already applied to my lab in the last few months, I am sorry but circumstances have changed and I will not be accepting a summer intern this year. If you remain interested for next year, please send me an application by email in January/February 2026 for positions starting May 2026. Undergraduate interns are encouraged to apply through an internal IRCM scholarship program. Find information here if you would like more information. Interviews take place in late February.
I will be welcoming interns for course credit again starting in the Fall 2025 or Winter 2026 semesters. Please apply direct to me via email.
For everyone interested: To apply, email a cover letter (detailing your interest and fit for our laboratory), CV, and most recent transcripts directly to Dr. Jennifer Estall.
POSTDOCTORAL FELLOWSHIP in Islet/Beta Cell Biology & RNA Therapeutics
The Cardiometabolic Health Centre of the IRCM invites applications for a Postdoctoral Fellowship in islet and beta cell biology, with a specialized focus on therapeutic development and in vivo beta cell targeting. Our lab is dedicated to uncovering innovative strategies to treat diabetes through precise modulation of beta cell function and survival.
Research Focus
This CIHR- and industry-funded position offers the opportunity to contribute to cutting-edge projects aimed at:
- Developing and evaluating the biological and physiological effects of novel therapeutics designed to enhance beta cell function and mass
- Designing and implementing strategies for in vivo targeting of beta cells
- Characterizing islet and beta cell responses to therapeutic interventions in preclinical models
- Employing advanced in vivo imaging, delivery technologies, and functional assays
Qualifications
- Ph.D. in Cell Biology, Physiology, Molecular Biology, Pharmacology, or a related field
- Strong background in islet biology, endocrine physiology, or metabolic disease
- Hands-on experience with in vivo models of diabetes (e.g., STZ, NOD, diet-induced obesity models) is required
- Familiarity with techniques such as glucose tolerance testing, insulin assays, and islet isolation
- Experience with cell culture and standard molecular biology techniques (e.g. Western blotting, ELISAs, immunostaining) required
- Excellent problem-solving abilities, a strong work ethic, and the ability to work both independently and collaboratively
We Offer
- A vibrant research environment with access to state-of-the-art facilities
- A lab with strong expertise in diabetes and islet biology, and a highly collaborative and dynamic team.
- Affiliation with the University of Montreal or McGill University
- Medical and dental benefits (through university affiliation)
- Mentorship from established leaders in diabetes and beta cell biology (CIRTN network membership)
- Opportunities for authorship, conference travel, industry internships, and career advancement
- Competitive salary range: $45,000 – 80,000 / yr (based on experience and successful external funding). Starting two-year contract with opportunities for renewal.
To Apply
Start date is flexible, but ideally before August 1st, 2025. Interested candidates should send a cover letter summarizing research interests and experience, a current CV, and contact details for three references to:
Dr Jennifer Estall
jennifer.estall@ircm.qc.ca